semaglutide and muscle building loss: Hidden risk for plans and PBMs Bodyfat loss with some muscle

doi: 10.3389/fphar.2025.1438318 Received 31 May 2024 Accepted 11 April 2025 Published 15 May 2025 Volume 16 - 2025 Edited by Bernd Rosenkranz, Fundisa African Academy of Medicines Development, South Africa Reviewed by C

Recently, Semaglutide was also FDA-approved for weight loss

The total weekly exposure stays at 1.7 mg

However, despite these advantages, the clinical use of native GLP-1 is significantly limited by its short plasma half-life (12 min), owing to rapid enzymatic degradation by DPP-4 and renal clearance

Dakle, Ozempic je lek koji sadri i semaglutid i namenjen je za leenje dijabetesa tipa 2

Shi S, Shuang S, Xiangdong L, Guoqiang Z, Feng D, Wenshuang Z, et al